New Altesa BioSciences Data: Vapendavir Demonstrates Anti-Viral Activity Against All Three Rhinovirus Species
In vivo, in vitro, and in silico data indicate vapendavir, the only clinical stage, direct-acting antiviral for rhinovirus, works against Rhinovirus C (RV-C) PRAGUE, May 12, 2026 /PRNewswire/ -- Altesa BioSciences presented new research at the 2026 International Conference on Antiviral...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- CHIME Announces New Board Members and Officers, Strengthening Leadership Through 2029
- Minnesota Dental Association Announces 2026-2027 Officers and Trustees
- Make Time Wellness Expands Access to Women's Brain Health with Meijer Launch and Return to QVC
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →